Back to Search Start Over

Synthesis and Structural Characterization of Novel Trihalo-sulfone Inhibitors of WNK1.

Authors :
Rodriguez M
Kannangara A
Chlebowicz J
Akella R
He H
Tambar UK
Goldsmith EJ
Source :
ACS medicinal chemistry letters [ACS Med Chem Lett] 2022 Sep 23; Vol. 13 (10), pp. 1678-1684. Date of Electronic Publication: 2022 Sep 23 (Print Publication: 2022).
Publication Year :
2022

Abstract

With No lysine (K) [WNK] kinases are structurally unique serine/threonine protein kinases that have therapeutic potential for blood pressure regulation and cancer. A novel class of trihalo-sulfone compounds was identified by high-throughput screening. Trihalo-sulfone 1 emerged as an effective inhibitor of WNK1 with an IC <subscript>50</subscript> value of 1.6 μM. Herein, we define chemical features necessary for inhibition of WNK1 using chemical synthesis and X-ray crystallography. Analogues that probed the role of specific functional groups to the inhibitory activity were synthesized. X-ray structures of trihalo-sulfone 1 and a second trihalo-sulfone 23 bound to WNK1 revealed active site binding to two of the three previously defined canonical inhibitor binding pockets as well as a novel binding site for the trihalo-sulfone moiety. The elucidation of these novel interaction sites may allow for the strategic design of even more selective and potent WNK inhibitors.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2022 American Chemical Society.)

Details

Language :
English
ISSN :
1948-5875
Volume :
13
Issue :
10
Database :
MEDLINE
Journal :
ACS medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
36262391
Full Text :
https://doi.org/10.1021/acsmedchemlett.2c00216